Multibagger stock giving 256% returns in a year performed brilliantly

Penny Stocks: Pharma sector’s well-known company Sudarshan Pharma Industries Ltd has released spectacular results of the fourth quarter (Q4) of FY 2024-25. The company has recorded a net profit of ₹ 10.03 crore in the quarter ended 31 March 2025, showing an increase of about 52% against the same period of the same period of the previous year.

If we talk about standalone data, then the net profit of the company was ₹ 9.95 crore, while it was ₹ 6.46 crore in the same quarter a year ago. That is, on the standalone basis, the company has shown a tremendous increase of 54%.

Strong revenue from operation

During the quarter ended March 2024, the consolidated revenue of Sudarshan Pharma Industries was ₹ 277.26 crore, which reflects an increase of 16.6% against the previous year’s ₹ 237.74 crore.

Investors got tremendous returns

Sudarshan Pharma’s share available at a price of less than Rs 30 has proved to be a multibagger for investors. In the last one year, the company has given a great return of 256% to its investors.
On Friday, when there was an atmosphere of decline in the market, the stock of Sudarshan Pharma saw a rise of about 2%.

Recent move and technical level

However, in the last one month, the company’s shares have seen a 17% decline due to the huge upheaval in the stock market.

• 52 Week High: ₹ 53.50

• Take 52 Week: ₹ 5.82

• Current market cap: ₹ 656 crore

It is worth noting that in November last year, Sudarshan Pharma Industries split a 10: 1 of its shares, after which the face value of the share was reduced to ₹ 1 per share.

Aadhaar Card Security Tips: Know when and where your Aadhaar was used, just a few clicks